Precision Medicine Market Size, Share and Demand Forecast to 2033

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global Precision Medicine Market Size Analysis

Global Precision Medicine Market Introduction
By Ecosystem
1. Introduction
  1. Ecosystem By Value
2. Applied Sciences
  1. By Value
3. Precision Diagnostics
  1. By Value
4. Precision Therapeutics
  1. By Value
5. Digital Health and Information Technology
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Oncology
  1. By Value
3. Neurology/psychiatry
  1. By Value
4. Infectious diseases
  1. By Value
5. Gastroenterology
  1. By Value
6. Cardiovascular
  1. By Value
7. Endocrinology
  1. By Value
8. Rheumatology
  1. By Value

North America Market Analysis

Introduction
By Ecosystem
1. Introduction
  1. Ecosystem By Value
2. Applied Sciences
  1. By Value
3. Precision Diagnostics
  1. By Value
4. Precision Therapeutics
  1. By Value
5. Digital Health and Information Technology
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Oncology
  1. By Value
3. Neurology/psychiatry
  1. By Value
4. Infectious diseases
  1. By Value
5. Gastroenterology
  1. By Value
6. Cardiovascular
  1. By Value
7. Endocrinology
  1. By Value
8. Rheumatology
  1. By Value
U.S.
1. By Ecosystem
  1. Introduction
    1. Ecosystem By Value
  2. Applied Sciences
    1. By Value
  3. Precision Diagnostics
    1. By Value
  4. Precision Therapeutics
    1. By Value
  5. Digital Health and Information Technology
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Oncology
    1. By Value
  3. Neurology/psychiatry
    1. By Value
  4. Infectious diseases
    1. By Value
  5. Gastroenterology
    1. By Value
  6. Cardiovascular
    1. By Value
  7. Endocrinology
    1. By Value
  8. Rheumatology
    1. By Value
Canada

Europe Market Analysis

Introduction
By Ecosystem
1. Introduction
  1. Ecosystem By Value
2. Applied Sciences
  1. By Value
3. Precision Diagnostics
  1. By Value
4. Precision Therapeutics
  1. By Value
5. Digital Health and Information Technology
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Oncology
  1. By Value
3. Neurology/psychiatry
  1. By Value
4. Infectious diseases
  1. By Value
5. Gastroenterology
  1. By Value
6. Cardiovascular
  1. By Value
7. Endocrinology
  1. By Value
8. Rheumatology
  1. By Value
U.K.
1. By Ecosystem
  1. Introduction
    1. Ecosystem By Value
  2. Applied Sciences
    1. By Value
  3. Precision Diagnostics
    1. By Value
  4. Precision Therapeutics
    1. By Value
  5. Digital Health and Information Technology
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Oncology
    1. By Value
  3. Neurology/psychiatry
    1. By Value
  4. Infectious diseases
    1. By Value
  5. Gastroenterology
    1. By Value
  6. Cardiovascular
    1. By Value
  7. Endocrinology
    1. By Value
  8. Rheumatology
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Ecosystem
1. Introduction
  1. Ecosystem By Value
2. Applied Sciences
  1. By Value
3. Precision Diagnostics
  1. By Value
4. Precision Therapeutics
  1. By Value
5. Digital Health and Information Technology
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Oncology
  1. By Value
3. Neurology/psychiatry
  1. By Value
4. Infectious diseases
  1. By Value
5. Gastroenterology
  1. By Value
6. Cardiovascular
  1. By Value
7. Endocrinology
  1. By Value
8. Rheumatology
  1. By Value
China
1. By Ecosystem
  1. Introduction
    1. Ecosystem By Value
  2. Applied Sciences
    1. By Value
  3. Precision Diagnostics
    1. By Value
  4. Precision Therapeutics
    1. By Value
  5. Digital Health and Information Technology
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Oncology
    1. By Value
  3. Neurology/psychiatry
    1. By Value
  4. Infectious diseases
    1. By Value
  5. Gastroenterology
    1. By Value
  6. Cardiovascular
    1. By Value
  7. Endocrinology
    1. By Value
  8. Rheumatology
    1. By Value
Korea
Japan
India
Australia
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Ecosystem
1. Introduction
  1. Ecosystem By Value
2. Applied Sciences
  1. By Value
3. Precision Diagnostics
  1. By Value
4. Precision Therapeutics
  1. By Value
5. Digital Health and Information Technology
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Oncology
  1. By Value
3. Neurology/psychiatry
  1. By Value
4. Infectious diseases
  1. By Value
5. Gastroenterology
  1. By Value
6. Cardiovascular
  1. By Value
7. Endocrinology
  1. By Value
8. Rheumatology
  1. By Value
UAE
1. By Ecosystem
  1. Introduction
    1. Ecosystem By Value
  2. Applied Sciences
    1. By Value
  3. Precision Diagnostics
    1. By Value
  4. Precision Therapeutics
    1. By Value
  5. Digital Health and Information Technology
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Oncology
    1. By Value
  3. Neurology/psychiatry
    1. By Value
  4. Infectious diseases
    1. By Value
  5. Gastroenterology
    1. By Value
  6. Cardiovascular
    1. By Value
  7. Endocrinology
    1. By Value
  8. Rheumatology
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Ecosystem
1. Introduction
  1. Ecosystem By Value
2. Applied Sciences
  1. By Value
3. Precision Diagnostics
  1. By Value
4. Precision Therapeutics
  1. By Value
5. Digital Health and Information Technology
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Oncology
  1. By Value
3. Neurology/psychiatry
  1. By Value
4. Infectious diseases
  1. By Value
5. Gastroenterology
  1. By Value
6. Cardiovascular
  1. By Value
7. Endocrinology
  1. By Value
8. Rheumatology
  1. By Value
Brazil
1. By Ecosystem
  1. Introduction
    1. Ecosystem By Value
  2. Applied Sciences
    1. By Value
  3. Precision Diagnostics
    1. By Value
  4. Precision Therapeutics
    1. By Value
  5. Digital Health and Information Technology
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Oncology
    1. By Value
  3. Neurology/psychiatry
    1. By Value
  4. Infectious diseases
    1. By Value
  5. Gastroenterology
    1. By Value
  6. Cardiovascular
    1. By Value
  7. Endocrinology
    1. By Value
  8. Rheumatology
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

Precision Medicine Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

Bristol-Myers Squibb Company
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
Illumina Inc.
Pacific Biosciences of California Inc.
AstraZeneca PLC
Eli Lilly and Company
Merck & Co. Inc.
Premaitha Health plc
QIAGEN N.V.
Johnson and Johnson
Asuragen Inc.

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment